Literature DB >> 32349537

Hepatitis B infection outcome is associated with novel human leukocyte antigen variants in Ghanaian cohort.

Kwesi Z Tandoh1,2, Kwadwo A Kusi1,2,3, Timothy N Archampong4, Isaac Boamah5, Osbourne Quaye1,2.   

Abstract

IMPACT STATEMENT: Genetic association studies can determine the effect size of gene loci on disease outcomes. In the arena of HBV infections, HLA alleles that associate with HBV outcomes can be used in clinical management decisions. This potential translational utility can shape the future management of HBV infections by identifying at-risk individuals and tailoring medical interventions accordingly. This precision medicine motif is currently only a nascent idea. However, it has stakes that may well override the current "wait and see" approach of clinical management of HBV infections. Here, we have identified HLA alleles associated with HBV outcome in a Ghanaian cohort. Our findings support the motif that HLA alleles associate with HBV outcome along geo-ethnic lines. This buttresses the need for further population pivoted studies. In the long term, our findings add to efforts towards the development of an HLA molecular-based algorithm for predicting HBV infection outcomes.

Entities:  

Keywords:  Human leukocyte antigen; association; chronic hepatitis B infection; genetics; immunology; virology

Mesh:

Substances:

Year:  2020        PMID: 32349537      PMCID: PMC7273892          DOI: 10.1177/1535370220921118

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  25 in total

Review 1.  Hepatitis B virus infection.

Authors:  W M Lee
Journal:  N Engl J Med       Date:  1997-12-11       Impact factor: 91.245

2.  CD8(+) T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection.

Authors:  Robert Thimme; Stefan Wieland; Carola Steiger; John Ghrayeb; Keith A Reimann; Robert H Purcell; Francis V Chisari
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

3.  Hapl-o-Mat: open-source software for HLA haplotype frequency estimation from ambiguous and heterogeneous data.

Authors:  Christian Schäfer; Alexander H Schmidt; Jürgen Sauter
Journal:  BMC Bioinformatics       Date:  2017-05-30       Impact factor: 3.169

4.  HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage.

Authors:  M Carrington; G W Nelson; M P Martin; T Kissner; D Vlahov; J J Goedert; R Kaslow; S Buchbinder; K Hoots; S J O'Brien
Journal:  Science       Date:  1999-03-12       Impact factor: 47.728

5.  HLA Haplotype Frequencies and Genetic Profiles of the Kuwaiti Population.

Authors:  Reem Ameen; Salem H Al Shemmari; Steven G E Marsh
Journal:  Med Princ Pract       Date:  2019-03-15       Impact factor: 1.927

Review 6.  Hepatitis B virus burden in developing countries.

Authors:  Rosa Zampino; Adriana Boemio; Caterina Sagnelli; Loredana Alessio; Luigi Elio Adinolfi; Evangelista Sagnelli; Nicola Coppola
Journal:  World J Gastroenterol       Date:  2015-11-14       Impact factor: 5.742

7.  Association between an MHC class II allele and clearance of hepatitis B virus in the Gambia.

Authors:  M R Thursz; D Kwiatkowski; C E Allsopp; B M Greenwood; H C Thomas; A V Hill
Journal:  N Engl J Med       Date:  1995-04-20       Impact factor: 91.245

Review 8.  Relationship between HLA-DR gene polymorphisms and outcomes of hepatitis B viral infections: a meta-analysis.

Authors:  Ze-Hui Yan; Yi Fan; Xiao-Hong Wang; Qing Mao; Guo-Hong Deng; Yu-Ming Wang
Journal:  World J Gastroenterol       Date:  2012-06-28       Impact factor: 5.742

9.  Comprehensive analysis of class I and class II HLA antigens and chronic hepatitis B virus infection.

Authors:  Chloe L Thio; David L Thomas; Peter Karacki; Xiaojiang Gao; Darlene Marti; Richard A Kaslow; James J Goedert; Margaret Hilgartner; Steffanie A Strathdee; Priya Duggal; Stephen J O'Brien; Jacquie Astemborski; Mary Carrington
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

Review 10.  Clinical Relevance of HLA Gene Variants in HBV Infection.

Authors:  Li Wang; Zhi-Qiang Zou; Kai Wang
Journal:  J Immunol Res       Date:  2016-05-08       Impact factor: 4.818

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.